| 000 | 01003 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516015156.0 | ||
| 264 | 0 | _c20110131 | |
| 008 | 201101s 0 0 eng d | ||
| 022 | _a1524-4628 | ||
| 024 | 7 |
_a10.1161/STROKEAHA.110.592394 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFisher, Marc | |
| 245 | 0 | 0 |
_aNew approaches to neuroprotective drug development. _h[electronic resource] |
| 260 |
_bStroke _cJan 2011 |
||
| 300 |
_aS24-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aBrain Ischemia _xpathology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
| 650 | 0 | 4 | _aReperfusion |
| 650 | 0 | 4 |
_aReperfusion Injury _xpathology |
| 650 | 0 | 4 |
_aStroke _xpathology |
| 773 | 0 |
_tStroke _gvol. 42 _gno. 1 Suppl _gp. S24-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/STROKEAHA.110.592394 _zAvailable from publisher's website |
| 999 |
_c20452979 _d20452979 |
||